Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BridgeBio Pharma Inc. June 20, 202593.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Jun 20, 2026 | BridgeBio Pharma Inc. | Shares withheld for tax | −788 | $66.27 | $52,221 |
| May 4, 2026 | Maze Therapeutics Inc. | Gift | −7,422 | — | — |
| Nov 19, 2025 | Maze Therapeutics Inc. | Other | +1,489 | — | — |
| Oct 23, 2025 | Maze Therapeutics Inc. | Gift | −28,423 | — | — |
| Aug 11, 2025 | BridgeBio Pharma Inc. | Open-market sale | −50,000 | $48.00 | $2,400,000 |
| Aug 8, 2025 | BridgeBio Pharma Inc. | Open-market sale | −191,662 | $45.87 | $8,791,536 |
| Aug 8, 2025 | BridgeBio Pharma Inc. | Open-market sale | −58,338 | $46.64 | $2,720,884 |
| Jun 27, 2025 | BridgeBio Pharma Inc. | Gift | −20,000 | — | — |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Feb 3, 2025 | Maze Therapeutics Inc. | Derivative conversion | +8,807 | — | — |
| Feb 3, 2025 | Maze Therapeutics Inc. | Derivative conversion | +20,717 | — | — |
| Feb 3, 2025 | Maze Therapeutics Inc. | Derivative conversion | +7,422 | — | — |
| Feb 16, 2024 | BridgeBio Pharma Inc. | Option exercise | +3,760 | — | — |
| Feb 16, 2024 | BridgeBio Pharma Inc. | Shares withheld for tax | −1,509 | $37.21 | $56,150 |
Questions about Charles J. Homcy
What boards is Charles J. Homcy on?
Charles J. Homcy sits on the boards of BridgeBio Pharma Inc. and Maze Therapeutics Inc.
How long has Charles J. Homcy served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.